Ladenburg Thalmann Financial Services’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $13K | Buy |
279
+113
| +68% | +$5.27K | ﹤0.01% | 4372 |
|
|
2019
Q3 | $7K | Hold |
166
| – | – | ﹤0.01% | 4546 |
|
|
2019
Q2 | $11K | Buy |
166
+67
| +68% | +$4.44K | ﹤0.01% | 4397 |
|
|
2019
Q1 | $7K | Hold |
99
| – | – | ﹤0.01% | 4539 |
|
|
2018
Q4 | $5K | Buy |
+99
| New | +$5K | ﹤0.01% | 4608 |
|
|
2018
Q3 | – | Sell |
-23
| Closed | -$1K | – | 5273 |
|
|
2018
Q2 | $1K | Hold |
23
| – | – | ﹤0.01% | 5012 |
|
|
2018
Q1 | $1K | Sell |
23
-3,250
| -99% | -$141K | ﹤0.01% | 5012 |
|
|
2017
Q4 | $152K | Buy |
3,273
+3,030
| +1,247% | +$141K | ﹤0.01% | 2421 |
|
|
2017
Q3 | $13K | Buy |
243
+200
| +465% | +$10.7K | ﹤0.01% | 3943 |
|
|
2017
Q2 | $3K | Sell |
43
-100
| -70% | -$6.98K | ﹤0.01% | 4490 |
|
|
2017
Q1 | $10K | Sell |
143
-16
| -10% | -$1.12K | ﹤0.01% | 3991 |
|
|
2016
Q4 | $12K | Buy |
159
+100
| +169% | +$7.55K | ﹤0.01% | 3781 |
|
|
2016
Q3 | $5K | Buy |
59
+53
| +883% | +$4.49K | ﹤0.01% | 4170 |
|
|
2016
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 4820 |
|
|
2016
Q1 | $0 | Sell |
6
-6
| -50% | – | ﹤0.01% | 4778 |
|
|
2015
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 4533 |
|
|
2015
Q3 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 4441 |
|
|
2014
Q4 | – | Sell |
-8
| Closed | – | – | 4418 |
|
|
2014
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 4010 |
|